TELA Bio, Inc.
TELA
$0.57
-$0.05-8.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.62% | 6.08% | 3.18% | -7.81% | 18.91% |
| Total Depreciation and Amortization | -0.20% | 15.88% | 23.67% | 26.36% | 25.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7,768.93% | 1,451.13% | 1,279.41% | 1,298.61% | -98.53% |
| Change in Net Operating Assets | 130.75% | 82.11% | -65.13% | 35.77% | -145.29% |
| Cash from Operations | 32.16% | 31.55% | 20.78% | 15.41% | -1.81% |
| Capital Expenditure | 54.70% | 33.23% | 43.52% | 10.38% | -61.87% |
| Sale of Property, Plant, and Equipment | -76.21% | -79.83% | -89.55% | -87.83% | 45,233.33% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -80.99% | -89.57% | -99.32% | -102.54% | 843.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -72.53% | 7,972.23% | 8,659.55% | -8.09% | -6.72% |
| Repurchase of Common Stock | 44.44% | 41.44% | 39.66% | 35.50% | -27.68% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -40.20% | 24,936.84% | 29,682.64% | -7.89% | -6.94% |
| Foreign Exchange rate Adjustments | -875.00% | 100.00% | -2,046.67% | -183.98% | -82.93% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -130.97% | 130.51% | 122.03% | -21.88% | 19.42% |